Prostate Cancer in Transplant Receivers—A Narrative Review on Oncological Outcomes

Prostate Cancer in Transplant Receivers—A Narrative Review on Oncological Outcomes

Prostate cancer (PCa) is a low tumor mutational burden (TMB) cancer with a poor response to immunotherapy. Nonetheless, immunotherapy can be useful, especially in metastatic castration-resistant PCa (mCRPC). Increased cytotoxic T lymphocytes (CTLs) density is correlated with a shorter overall surviv...

Full description

Bibliographic Details
Main Authors: Karolina Hanusz, Piotr Domański, Kacper Strojec, Piotr Zapała, Łukasz Zapała, Piotr Radziszewski
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Biomedicines
Subjects:
prostate cancer
transplant
immunosuppression
progression
metastatic prostate cancer
Online Access:https://www.mdpi.com/2227-9059/11/11/2941

Similar Items

Similar Items